Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities

M. A. Cosenza-Nashat, A. Bauman, M. L. Zhao, S. Morgello, H. S. Suh, Sunhee C. Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aims: Cannabinoids have been proposed for treating various neurodegenerative disorders and as adjunct therapy for HIV+ patients with neurologic sequelae. The expression of cannabinoid receptors (CB1 and CB2) has been reported in neurodegenerative diseases and in simian immunodeficiency virus encephalitis, yet the receptor expression in the central nervous system of HIV+ individuals is not known. Methods: An anti-CB1 antibody and two anti-CB2 antibodies were employed for immunohistochemistry in the cerebral cortex and white matter of HIV encephalitis (HIVE) and HIV-associated comorbidities, as well as control brains (HIV- and HIV+). Results: By quantitative image analysis, we observed that CB1 was increased in HIVE brains and those with comorbidities, while CB2 was significantly increased in the white matter of HIVE. Morphologically, CB1 was present in neurones, and both CB1 and CB2 were present in meningeal macrophages and subpial glia in all brains. In HIVE, CB1 was found in white matter microglia and perivascular cells, while CB2 was increased in microglia, astrocytes and perivascular macrophages. Double immunofluorescence with cell-specific markers and immunoblots on primary cultured microglia and astrocytes substantiated the glial localization of the cannabinoid receptors and specificity of the antibodies. Conclusions: Our study indicates that cannabinoid receptor expression occurs in glia in HIVE brains, and this may have ramifications for the potential use of cannabinoid ligands in HIV-infected patients.

Original languageEnglish (US)
Pages (from-to)464-483
Number of pages20
JournalNeuropathology and Applied Neurobiology
Volume37
Issue number5
DOIs
StatePublished - Aug 2011

Fingerprint

Cannabinoid Receptors
Encephalitis
Comorbidity
HIV
Microglia
Neuroglia
Cannabinoids
Brain
Astrocytes
Neurodegenerative Diseases
Anti-Idiotypic Antibodies
Macrophages
Cannabinoid Receptor CB2
Cannabinoid Receptor CB1
Simian Immunodeficiency Virus
Antibody Specificity
Cerebral Cortex
Nervous System
Fluorescent Antibody Technique
Central Nervous System

Keywords

  • Astrocytes
  • Cannabinoid receptor
  • Human
  • Immunohistochemistry
  • Inflammation
  • Microglia

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neurology
  • Histology
  • Physiology (medical)

Cite this

Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities. / Cosenza-Nashat, M. A.; Bauman, A.; Zhao, M. L.; Morgello, S.; Suh, H. S.; Lee, Sunhee C.

In: Neuropathology and Applied Neurobiology, Vol. 37, No. 5, 08.2011, p. 464-483.

Research output: Contribution to journalArticle

Cosenza-Nashat, M. A. ; Bauman, A. ; Zhao, M. L. ; Morgello, S. ; Suh, H. S. ; Lee, Sunhee C. / Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities. In: Neuropathology and Applied Neurobiology. 2011 ; Vol. 37, No. 5. pp. 464-483.
@article{d9c6335506a748f382a2d796d4915e3e,
title = "Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities",
abstract = "Aims: Cannabinoids have been proposed for treating various neurodegenerative disorders and as adjunct therapy for HIV+ patients with neurologic sequelae. The expression of cannabinoid receptors (CB1 and CB2) has been reported in neurodegenerative diseases and in simian immunodeficiency virus encephalitis, yet the receptor expression in the central nervous system of HIV+ individuals is not known. Methods: An anti-CB1 antibody and two anti-CB2 antibodies were employed for immunohistochemistry in the cerebral cortex and white matter of HIV encephalitis (HIVE) and HIV-associated comorbidities, as well as control brains (HIV- and HIV+). Results: By quantitative image analysis, we observed that CB1 was increased in HIVE brains and those with comorbidities, while CB2 was significantly increased in the white matter of HIVE. Morphologically, CB1 was present in neurones, and both CB1 and CB2 were present in meningeal macrophages and subpial glia in all brains. In HIVE, CB1 was found in white matter microglia and perivascular cells, while CB2 was increased in microglia, astrocytes and perivascular macrophages. Double immunofluorescence with cell-specific markers and immunoblots on primary cultured microglia and astrocytes substantiated the glial localization of the cannabinoid receptors and specificity of the antibodies. Conclusions: Our study indicates that cannabinoid receptor expression occurs in glia in HIVE brains, and this may have ramifications for the potential use of cannabinoid ligands in HIV-infected patients.",
keywords = "Astrocytes, Cannabinoid receptor, Human, Immunohistochemistry, Inflammation, Microglia",
author = "Cosenza-Nashat, {M. A.} and A. Bauman and Zhao, {M. L.} and S. Morgello and Suh, {H. S.} and Lee, {Sunhee C.}",
year = "2011",
month = "8",
doi = "10.1111/j.1365-2990.2011.01177.x",
language = "English (US)",
volume = "37",
pages = "464--483",
journal = "Neuropathology and Applied Neurobiology",
issn = "0305-1846",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities

AU - Cosenza-Nashat, M. A.

AU - Bauman, A.

AU - Zhao, M. L.

AU - Morgello, S.

AU - Suh, H. S.

AU - Lee, Sunhee C.

PY - 2011/8

Y1 - 2011/8

N2 - Aims: Cannabinoids have been proposed for treating various neurodegenerative disorders and as adjunct therapy for HIV+ patients with neurologic sequelae. The expression of cannabinoid receptors (CB1 and CB2) has been reported in neurodegenerative diseases and in simian immunodeficiency virus encephalitis, yet the receptor expression in the central nervous system of HIV+ individuals is not known. Methods: An anti-CB1 antibody and two anti-CB2 antibodies were employed for immunohistochemistry in the cerebral cortex and white matter of HIV encephalitis (HIVE) and HIV-associated comorbidities, as well as control brains (HIV- and HIV+). Results: By quantitative image analysis, we observed that CB1 was increased in HIVE brains and those with comorbidities, while CB2 was significantly increased in the white matter of HIVE. Morphologically, CB1 was present in neurones, and both CB1 and CB2 were present in meningeal macrophages and subpial glia in all brains. In HIVE, CB1 was found in white matter microglia and perivascular cells, while CB2 was increased in microglia, astrocytes and perivascular macrophages. Double immunofluorescence with cell-specific markers and immunoblots on primary cultured microglia and astrocytes substantiated the glial localization of the cannabinoid receptors and specificity of the antibodies. Conclusions: Our study indicates that cannabinoid receptor expression occurs in glia in HIVE brains, and this may have ramifications for the potential use of cannabinoid ligands in HIV-infected patients.

AB - Aims: Cannabinoids have been proposed for treating various neurodegenerative disorders and as adjunct therapy for HIV+ patients with neurologic sequelae. The expression of cannabinoid receptors (CB1 and CB2) has been reported in neurodegenerative diseases and in simian immunodeficiency virus encephalitis, yet the receptor expression in the central nervous system of HIV+ individuals is not known. Methods: An anti-CB1 antibody and two anti-CB2 antibodies were employed for immunohistochemistry in the cerebral cortex and white matter of HIV encephalitis (HIVE) and HIV-associated comorbidities, as well as control brains (HIV- and HIV+). Results: By quantitative image analysis, we observed that CB1 was increased in HIVE brains and those with comorbidities, while CB2 was significantly increased in the white matter of HIVE. Morphologically, CB1 was present in neurones, and both CB1 and CB2 were present in meningeal macrophages and subpial glia in all brains. In HIVE, CB1 was found in white matter microglia and perivascular cells, while CB2 was increased in microglia, astrocytes and perivascular macrophages. Double immunofluorescence with cell-specific markers and immunoblots on primary cultured microglia and astrocytes substantiated the glial localization of the cannabinoid receptors and specificity of the antibodies. Conclusions: Our study indicates that cannabinoid receptor expression occurs in glia in HIVE brains, and this may have ramifications for the potential use of cannabinoid ligands in HIV-infected patients.

KW - Astrocytes

KW - Cannabinoid receptor

KW - Human

KW - Immunohistochemistry

KW - Inflammation

KW - Microglia

UR - http://www.scopus.com/inward/record.url?scp=79960209990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960209990&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2990.2011.01177.x

DO - 10.1111/j.1365-2990.2011.01177.x

M3 - Article

C2 - 21450051

AN - SCOPUS:79960209990

VL - 37

SP - 464

EP - 483

JO - Neuropathology and Applied Neurobiology

JF - Neuropathology and Applied Neurobiology

SN - 0305-1846

IS - 5

ER -